Offer - Urjas Oil for just ₹ 1
Ampholyn is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Fungal Infections. Other than this, Ampholyn has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Ampholyn is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Ampholyn include Nausea or vomiting, Fever, Headache. Apart from the aforementioned side effects, Ampholyn can also lead to other problems, which have been listed below. Such side effects of Ampholyn normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Ampholyn's effect during pregnancy is Severe and Mild while nursing. Warnings related to Ampholyn's effects on the liver, heart and kidney, if any, have been listed below.
Some other conditions that can be affected by Ampholyn are listed in the contraindications section below.
Additionally, Ampholyn may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Ampholyn is not safe while driving, and is not addiction.
Ampholyn is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Neonates (0 to 1 month) |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Ampholyn is used -
Mild
Common
Is the use of Ampholyn safe for pregnant women?
Ampholyn should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Ampholyn safe during breastfeeding?
Side effects of Ampholyn for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Ampholyn on the Kidneys?
Ampholyn may have mild side effects on the kidneys.
What is the effect of Ampholyn on the Liver?
Information about safety of Ampholyn for the liver is not available since scientific research on this is yet to be done.
What is the effect of Ampholyn on the Heart?
Side effects of Ampholyn rarely affect the heart.
Ampholyn should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ampholyn unless your doctor advises you to do so -
Is this Ampholyn habit forming or addictive?
No, there is no any evidence that Ampholyn is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Ampholyn as you may feel sleepy.
Is it safe?
Yes, but take Ampholyn only as per medical advice.
Is it able to treat mental disorders?
Ampholyn is unable to treat or cure mental disorders.
Interaction between Food and Ampholyn
Due to a lack of research, nothing can be said about the consequences of taking Ampholyn together with food.
Interaction between Alcohol and Ampholyn
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Ampholyn.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amphotericin B
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 787-789
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 154-157